Development

INSIGHTS ON DRUG DEVELOPMENT

Predicting Drug-Loading Limits In Tablet Formulations
Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.
Manufacturing Readiness Is The Next Frontier In Life Sciences AI
As AI compresses discovery timelines, molecules reach commercial manufacturing sooner and with less runway. Readiness starts upstream, where process knowledge transfers and execution data becomes the foundation for trustworthy AI.
Your AKTA Oligosynt™ System : It's More Than A Machine
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
Thermal Analysis In The Pharmaceutical Industry
Thermal analysis techniques provide valuable insights into pharmaceutical material properties, ensuring compatibility, stability, and quality control in drug development and production processes.

Overcoming Excipient Risks And Challenges For Parenteral Formulations
8/27/2025

Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
Cell Culture Media Filtration: Evaluating Cell Culture Performance
10/23/2025

Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
Assessing Particle Generation In A Single-Use Mixing System
11/13/2025

Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
Evolving Gene Editing For Rare Disease Drug Development
10/9/2025

Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
Accelerate FDA Approval With Fast Track Designation
7/3/2025

Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.

Selected Immunoassays

Explore a diverse range of immunoassays for hormone analysis, neurodegeneration, autoimmunity, and salivary diagnostics—each designed for high sensitivity, reproducibility, and ease of use.
FlexCHOICE Instrument Service Coverage

Unexpected downtime can drastically impact your organization’s ability to service customers and hinder innovation. With Waters FlexCHOICE: mySystem Coverage*, you can safeguard against lost productivity and unexpected downtime and spend more time on what matters most – your customers and your research.
Paediatric Drug Development And Manufacture

From formulation design to commercial supply, pediatric drug development requires expertise that supports accurate dosing, usability and scale.
Accelerate Molecules Through Development With Translational Pharmaceutics®

By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.
Custom Synthesis Services

For more than 30 years Curia has been meeting the custom synthesis needs of our clients.